Medtronic PLC vs Marqeta Inc — how do they compare? Medtronic PLC trades at $82.79 (market cap $106.61B), while Marqeta Inc trades at $17.22 (market cap $1.85B). The key difference: Medtronic PLC is far larger — about 57.6× Marqeta Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals.
| MDT | MQ | |
|---|---|---|
Market Cap | $106.61B | $1.85B |
Sector | Health | Technology |
52-Week High | $105.35 | $27.32 |
52-Week Low | $73.75 | $15.04 |
Enterprise Value | $125.36B | $1.15B |
Dividend Yield | 3.46% | — |
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →